Quick Answer
Dare Bioscience, Inc. reported Cash And Cash Equivalents At Carrying Value of $24.71 million for the year ending 2025.
- Dare Bioscience, Inc. showed an increase of +57.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Dare Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), Dare Bioscience, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 61.0%.
- Historical annual values: Fiscal year 2025: $24.71 million | Fiscal year 2024: $15.70 million | Fiscal year 2023: $10.48 million | Fiscal year 2022: $34.67 million | Fiscal year 2021: $51.67 million | Fiscal year 2020: $4.67 million | Fiscal year 2019: $4.78 million | Fiscal year 2018: $6.81 million | Fiscal year 2017: $7.56 million | Fiscal year 2016: $44.6 thousand | Fiscal year 2015: $219.4 thousand | Fiscal year 2014: $51.17 million | Fiscal year 2013: $5.49 million | Fiscal year 2012: $16.71 million | Fiscal year 2011: $15.35 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: